The Innovation Firm

Bin Wang, Ph.D.

Practice Areas

Technologies

Education

  • Baylor University Law School, J.D., cum laude
  • University of Texas, Ph.D. in Molecular Biology
  • Fudan University, Shanghai, China, B.S. in Genetics, People’s Scholarship for Excellence

Professional Associations

  • American Bar Association, Member of Intellectual Property Law, Science & Technology Law, and Litigation Sections
  • Member of the Biophysical Society; the American Heart Association
  • Reviewer, Proceedings of the National Academy of Sciences of the USA, 2014; PLOS ONE, 2013

Bin Wang, Ph.D.

Bin Wang, Ph.D. Attorney

Bin Wang, Ph.D.

Associate
Concord office
978.341.0036

Bin Wang is a patent attorney specializing in the areas of biotechnology, life sciences, and pharmaceuticals. Bin has prepared and prosecuted patent applications for small molecule therapeutics, therapeutic polypeptides and antibodies, therapeutic applications of adult stem cells, nanoparticle drug delivery compositions, and cancer diagnostics. Bin also has experience with U.S. and foreign trademark prosecution.

Bin’s representative areas of technical focus include:

  • Treatment or prevention for neurodegenerative diseases, cancers, ischemic stroke, autoimmune diseases, inflammatory diseases, bone marrow failure, viral infections, preterm labor, mitochondrial neurogastrointestinal encephalomyopathy, uterine contractility disorder, systemic endotoxemia using adult stem cells, steroid hormones, small molecule therapeutics, kinase inhibitors, modulator of cytokine, anti-aging agent, fungal etiologic agents, splice variants, cell-free DNA, RNAi silencing molecules, antibodies, erythrocytes, and dual targeting anti-cancer strategy.
  • Diagnostics and prognostics for traumatic brain injury, adrenocortical carcinoma, neurodegenerative diseases, and liver diseases, using whole genome sequencing, bioinformatics, microRNA markers, and breath test.
  • Methods of detecting genomic rearrangements, detecting heteroresistant pathogens, and distinguishing somatic versus germline variants in impure tumors.
  • Methods of nanoparticle formulation, stem-cell production, processing biological liquid tissue allografts, small RNA purification, bacterium subtyping, antigen retrieval, post-harvest protection of agricultural produce, biomarker creation, indexing next-generation amplicon sequences, and biological waste-water treatment.

Prior to joining the firm Bin served as a judicial extern at Law Clerk to The Eastern District of Texas, United States District Court Judge K. Nicole Mitchell. After completing her Ph.D., Bin was a Postdoctoral Fellow at Stanford University, a Postdoctoral Fellow and an Assistant Professor of Research at The University of Texas Health Science Center at San Antonio.  Bin has been the recipient of many awards and honors, including the Dean’s Postdoctoral Fellowship from Stanford University, the Dean's Academic Excellence Full Scholarship, Jim Barlow Memorial Award, Loy M. Simpkins Memorial Award, and Thomas M. Featherston, Jr. Estate Planning Award from Baylor Law School, and NIH Individual National Research Service Award.

Bin is the author of over twenty scientific articles and book contributions including: Development, Nature Immunology, Cell, Nature, Journal of General Physiology, Methods in Molecular Biology, American Journal of Physiology-Lung Cellular and Molecular Physiology, Molecular Psychiatry, Human Molecular Genetics, Invertebrate Neuroscience, Experimental Biology, Neuroscience, European Journal of Neuroscience, and Frontiers in Physiology. Bin wrote two book chapters, one for Encyclopedia of Basic Epilepsy Research and the other for Ion Channels, Methods and Protocols.

Bar Admissions

  • U.S. Patent and Trademark Office
  • Texas

Articles

Press Releases

  • Bin Wang, Ph.D. Joins the Hamilton Brook Smith Reynolds Life Sciences Team more
Biography

Bin Wang is a patent attorney specializing in the areas of biotechnology, life sciences, and pharmaceuticals. Bin has prepared and prosecuted patent applications for small molecule therapeutics, therapeutic polypeptides and antibodies, therapeutic applications of adult stem cells, nanoparticle drug delivery compositions, and cancer diagnostics. Bin also has experience with U.S. and foreign trademark prosecution.

Bin’s representative areas of technical focus include:

  • Treatment or prevention for neurodegenerative diseases, cancers, ischemic stroke, autoimmune diseases, inflammatory diseases, bone marrow failure, viral infections, preterm labor, mitochondrial neurogastrointestinal encephalomyopathy, uterine contractility disorder, systemic endotoxemia using adult stem cells, steroid hormones, small molecule therapeutics, kinase inhibitors, modulator of cytokine, anti-aging agent, fungal etiologic agents, splice variants, cell-free DNA, RNAi silencing molecules, antibodies, erythrocytes, and dual targeting anti-cancer strategy.
  • Diagnostics and prognostics for traumatic brain injury, adrenocortical carcinoma, neurodegenerative diseases, and liver diseases, using whole genome sequencing, bioinformatics, microRNA markers, and breath test.
  • Methods of detecting genomic rearrangements, detecting heteroresistant pathogens, and distinguishing somatic versus germline variants in impure tumors.
  • Methods of nanoparticle formulation, stem-cell production, processing biological liquid tissue allografts, small RNA purification, bacterium subtyping, antigen retrieval, post-harvest protection of agricultural produce, biomarker creation, indexing next-generation amplicon sequences, and biological waste-water treatment.

Prior to joining the firm Bin served as a judicial extern at Law Clerk to The Eastern District of Texas, United States District Court Judge K. Nicole Mitchell. After completing her Ph.D., Bin was a Postdoctoral Fellow at Stanford University, a Postdoctoral Fellow and an Assistant Professor of Research at The University of Texas Health Science Center at San Antonio.  Bin has been the recipient of many awards and honors, including the Dean’s Postdoctoral Fellowship from Stanford University, the Dean's Academic Excellence Full Scholarship, Jim Barlow Memorial Award, Loy M. Simpkins Memorial Award, and Thomas M. Featherston, Jr. Estate Planning Award from Baylor Law School, and NIH Individual National Research Service Award.

Bin is the author of over twenty scientific articles and book contributions including: Development, Nature Immunology, Cell, Nature, Journal of General Physiology, Methods in Molecular Biology, American Journal of Physiology-Lung Cellular and Molecular Physiology, Molecular Psychiatry, Human Molecular Genetics, Invertebrate Neuroscience, Experimental Biology, Neuroscience, European Journal of Neuroscience, and Frontiers in Physiology. Bin wrote two book chapters, one for Encyclopedia of Basic Epilepsy Research and the other for Ion Channels, Methods and Protocols.

Education
  • Baylor University Law School, J.D., cum laude
  • University of Texas, Ph.D. in Molecular Biology
  • Fudan University, Shanghai, China, B.S. in Genetics, People’s Scholarship for Excellence
Publications

Articles

Professional Associations
  • American Bar Association, Member of Intellectual Property Law, Science & Technology Law, and Litigation Sections
  • Member of the Biophysical Society; the American Heart Association
  • Reviewer, Proceedings of the National Academy of Sciences of the USA, 2014; PLOS ONE, 2013
News
  • Bin Wang, Ph.D. Joins the Hamilton Brook Smith Reynolds Life Sciences Team more
Bar Admissions
  • U.S. Patent and Trademark Office
  • Texas

Back to the Top